naltrexone and Autistic Disorder

naltrexone has been researched along with Autistic Disorder in 54 studies

Research

Studies (54)

TimeframeStudies, this research(%)All Research%
pre-19909 (16.67)18.7374
1990's35 (64.81)18.2507
2000's9 (16.67)29.6817
2010's0 (0.00)24.3611
2020's1 (1.85)2.80

Authors

AuthorsStudies
Sablaban, IM; Sivananthan, M1
Contejean, Y; Desjardins, S; Doyen, C; Kaye, K; Paubel, P1
Delaney, MA; Gratz, SS; Hyman, SB; Malone, RP1
Augusto, LM; Elchaar, GM; Maisch, NM; Wehring, HJ1
Good, P1
Buitelaar, JK; Nijhof, GJ; van England, H; Willemsen-Swinkels, SH1
Klimesch, W; Klingler, D; Lensing, P; Panksepp, J; Pap, V; Schimke, H; Szemes, G1
Adams, PB; Bluhm, LD; Campbell, M; Foltz, RL; Gonzalez, NM; Shay, J; Small, AM1
Gillberg, C1
Feldman, HM; Handen, BL; Janosky, JE; Kolmen, BK2
Benjamin, S; Gagnon, M; Price, E; Seek, A; Tresise, L1
Black, SL1
Adams, P; Anderson, LT; Campbell, M; Ernst, M; Gonzalez, NM; Small, AM1
Campbell, M; Devi, L; Ernst, M; Gonzalez, NM; Malone, RP; Silva, RR; Small, AM1
Bondoux, D; Bouvard, MP; Dugas, M; Launay, JM; Leboyer, M; Lensing, P; Plumet, MH; Recasens, C; Tabuteau, F; Waller-Perotte, D1
Buitelaar, JK; van Engeland, H; Weijnen, FG; Willemsen-Swinkels, SH1
Compagnon, M; Decocq, G; Kandelaft, N1
Campbell, M; Cueva, JE; Hallin, A; Schopler, E1
Campbell, M; Harris, JC1
Buitelaar, JK; van Engeland, H; Willemsen-Swinkels, SH1
Adesman, AR1
Batticane, N; Cioni, M; Gallo, F; Marchetti, B; Morale, MC; Nicolosi, A; Quattropani, MC; Scifo, R; Testa, N; Tirolo, C1
Calandra, C; Marchetti, B; Parrinello, MA; Scifo, R1
Buitelaar, JK; Van Engeland, H; Willemsen-Swinkels, S1
Blatt, SD; Botash, AS; Church, CC; Jean-Louis, F; Meguid, V; Siripornsawan, MP; Weinberger, HL1
Bernstein, GA; Cook, EH; Leonard, HL; March, JS; Riddle, MA; Swanson, JM1
Feldman, HM; Gonzaga, AM; Kolmen, BK1
Buitelaar, JK; van Berckelaer-Onnes, IA; van Engeland, H; Willemsen-Swinkels, SH1
Bajo, S; Cazzullo, AG; Musetti, L; Musetti, MC; Panerai, A; Sacerdote, P1
Chicz-DeMet, A; Hetrick, W; Marion, S; Sandman, CA; Talyor, D1
Hunsinger, DM; Nguyen, T; Raffa, RB; Zebraski, SE1
Chabane, N; Leboyer, M; Mouren-Simeoni, MC1
McDougle, CJ; Posey, DJ1
Allard, A; Bloom, AS; Dalrymple, N; Sears, L; Williams, PG1
Adam, H; Hackenberg, B; Huber, M; Klingler, D; Lensing, P; Panksepp, J; Saria, A1
Bouvard, MP; Dugas, M; Kerdelhue, B; Launay, JM; Leboyer, M; Lensing, P; Panksepp, J; Tabuteau, F; Waller, D1
Bouvard, M; Klingler, D; Lampl, C; Leboyer, M; Lensing, P; Panksepp, J; Plumet, MH1
Chicz-DeMet, A; Ellman, G; Heidorn, S; Hom, A; Wymore, M; Zingarelli, G1
Sloman, L1
Barron, JL; Hetrick, WP; Neri, CL; Sandman, CA; Taylor, DV; Touchette, P1
Lensing, P; Panksepp, J1
Barrett, RP; Feinstein, C; Hole, WT; Mercurio, A; Walters, AS1
Anderson, LT; Campbell, M; Choroco, MC; Locascio, JJ; Lynch, NS; Small, AM1
Knabe, R; Richard, J; Schulz, P1
Sandman, CA1
Lienemann, J; Walker, F1
Barrett, RP; Feinstein, C; Hole, WT1
Appelgate, K; Arthur-Smith, A; Hammock, MK; Herman, BH; Kuehl, K1
Bouvard, MP; Dugas, M; Leboyer, M1
Adams, P; Campbell, M; Foltz, RL; Monti, KM; Nobler, M; Overall, JE; Perry, R; Small, AM; Sokol, MS; Spencer, EK1
Panksepp, J; Sahley, TL1
Adams, P; Campbell, M; Curren, EL; Small, AM; Tesch, LM1
Thompson, DF; Thompson, GD1

Reviews

10 review(s) available for naltrexone and Autistic Disorder

ArticleYear
Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders.
    CNS drugs, 2005, Volume: 19, Issue:11

    Topics: Adolescent; Adrenergic alpha-Agonists; Antipsychotic Agents; Autistic Disorder; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Humans; Naltrexone; Nutrition Therapy; Selective Serotonin Reuptake Inhibitors; Vitamins

2005
Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
    The Annals of pharmacotherapy, 2006, Volume: 40, Issue:6

    Topics: Autistic Disorder; Child; Clinical Trials as Topic; Humans; Naltrexone; Narcotic Antagonists; Self-Injurious Behavior

2006
Treatment of autistic disorder.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1996, Volume: 35, Issue:2

    Topics: Antipsychotic Agents; Autistic Disorder; Behavior Therapy; Clomipramine; Clonidine; Fenfluramine; Humans; Naltrexone; Rehabilitation, Vocational; Selective Serotonin Reuptake Inhibitors; Speech Therapy

1996
Sudden infant death syndrome, child sexual abuse, and child development.
    Current opinion in pediatrics, 1999, Volume: 11, Issue:2

    Topics: Autistic Disorder; Child; Child Abuse, Sexual; Child, Preschool; Condylomata Acuminata; Fluoxetine; Humans; Infant; Infant, Newborn; Naltrexone; Narcotic Antagonists; Papillomaviridae; Papillomavirus Infections; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sudden Infant Death

1999
Anxiolytics, adrenergic agents, and naltrexone.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1999, Volume: 38, Issue:5

    Topics: Adolescent; Adolescent Psychiatry; Adrenergic Agonists; Anti-Anxiety Agents; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child Psychiatry; Clinical Trials as Topic; Depressive Disorder; Humans; Mental Disorders; Naltrexone; Narcotic Antagonists; Treatment Outcome

1999
Is there a basis for novel pharmacotherapy of autism?
    Life sciences, 2000, Aug-25, Volume: 67, Issue:14

    Topics: Amino Acid Sequence; Animals; Antipsychotic Agents; Autistic Disorder; Buspirone; Dietary Supplements; Humans; Immunoglobulins, Intravenous; Molecular Sequence Data; Naltrexone; Narcotic Antagonists; Risperidone; Secretin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists

2000
Opiate antagonists in children and adolescents.
    European child & adolescent psychiatry, 2000, Volume: 9 Suppl 1

    Topics: Adolescent; Adolescent Psychiatry; Alcoholism; Autistic Disorder; Child; Feeding and Eating Disorders; Female; Humans; Intellectual Disability; Male; Naltrexone; Narcotic Antagonists

2000
Pharmacotherapeutic management of autism.
    Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:4

    Topics: Adrenergic alpha-Agonists; Antipsychotic Agents; Autistic Disorder; Central Nervous System Stimulants; Humans; Naltrexone; Selective Serotonin Reuptake Inhibitors

2001
[Opiate hypothesis of the origin of early childhood autism and sequelae for psychopharmacotherapy].
    Zeitschrift fur Kinder- und Jugendpsychiatrie, 1992, Volume: 20, Issue:3

    Topics: Autistic Disorder; Brain; Child; Endorphins; Humans; Naltrexone; Narcotic Antagonists; Receptors, Opioid

1992
Use of medication in pervasive developmental disorders.
    The Psychiatric clinics of North America, 1991, Volume: 14, Issue:1

    Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child Development Disorders, Pervasive; Fenfluramine; Humans; Methylphenidate; Naltrexone; Psychotropic Drugs

1991

Trials

23 trial(s) available for naltrexone and Autistic Disorder

ArticleYear
Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.
    Archives of general psychiatry, 1995, Volume: 52, Issue:9

    Topics: Adolescent; Adult; Autistic Disorder; Comorbidity; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Humans; Incidence; Intellectual Disability; Male; Middle Aged; Naltrexone; Placebos; Psychiatric Status Rating Scales; Self-Injurious Behavior; Stereotyped Behavior; Treatment Outcome

1995
Naltrexone plasma levels, clinical response and effect on weight in autistic children.
    Psychopharmacology bulletin, 1994, Volume: 30, Issue:2

    Topics: Autistic Disorder; Body Weight; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Naltrexone; Treatment Outcome

1994
Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1995, Volume: 34, Issue:2

    Topics: Autistic Disorder; Child; Child, Preschool; Communication; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Naltrexone; Personality Assessment; Social Behavior

1995
Naltrexone in autistic children: behavioral symptoms and attentional learning.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1993, Volume: 32, Issue:6

    Topics: Attention; Autistic Disorder; Child; Child, Preschool; Discrimination Learning; Female; Humans; Male; Naltrexone; Psychiatric Status Rating Scales; Self-Injurious Behavior; Severity of Illness Index; Stereotyped Behavior; Treatment Outcome; Weight Loss

1993
Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children.
    Psychopharmacology bulletin, 1993, Volume: 29, Issue:2

    Topics: Autistic Disorder; beta-Endorphin; Child; Child, Preschool; Double-Blind Method; Female; Haloperidol; Humans; Male; Naltrexone

1993
Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study.
    Psychiatry research, 1995, Oct-16, Volume: 58, Issue:3

    Topics: Adolescent; Autistic Disorder; beta-Endorphin; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Neurotransmitter Agents; Personality Assessment

1995
Placebo-controlled acute dosage naltrexone study in young autistic children.
    Psychiatry research, 1995, Oct-16, Volume: 58, Issue:3

    Topics: Attention; Autistic Disorder; beta-Endorphin; Child; Child, Preschool; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydrocortisone; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Personality Assessment; Social Behavior

1995
Resolved: autistic children should have a trial of naltrexone.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1996, Volume: 35, Issue:2

    Topics: Autistic Disorder; Child; Child, Preschool; Double-Blind Method; Humans; Naltrexone; Narcotic Antagonists; Placebos

1996
The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.
    Biological psychiatry, 1996, Jun-15, Volume: 39, Issue:12

    Topics: Autistic Disorder; Child; Child, Preschool; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Personality Assessment; Social Behavior; Treatment Outcome

1996
Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone.
    Annali dell'Istituto superiore di sanita, 1996, Volume: 32, Issue:3

    Topics: Adolescent; Antigens, CD; Autistic Disorder; Behavior; beta-Endorphin; Child; Cross-Over Studies; Double-Blind Method; Female; Humans; Lymphocyte Subsets; Male; Naltrexone; Narcotic Antagonists

1996
Naltrexone in young autistic children: replication study and learning measures.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1997, Volume: 36, Issue:11

    Topics: Attention; Attention Deficit and Disruptive Behavior Disorders; Autistic Disorder; Child; Child, Preschool; Communication; Cross-Over Studies; Female; Humans; Learning; Male; Naltrexone; Narcotic Antagonists; Self Stimulation; Treatment Outcome

1997
Naltrexone and communication skills in young children with autism.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1999, Volume: 38, Issue:5

    Topics: Autistic Disorder; Child; Child, Preschool; Cross-Over Studies; Double-Blind Method; Female; Humans; Language; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Parent-Child Relations; Treatment Outcome; Verbal Behavior

1999
Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design.
    Journal of autism and developmental disorders, 1999, Volume: 29, Issue:2

    Topics: Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child, Preschool; Female; Humans; Interpersonal Relations; Male; Naltrexone; Social Adjustment

1999
Beta-endorphin levels in peripheral blood mononuclear cells and long-term naltrexone treatment in autistic children.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999, Volume: 9, Issue:4

    Topics: Autistic Disorder; beta-Endorphin; Child; Child, Preschool; Cognition; Humans; Leukocytes, Mononuclear; Naltrexone; Narcotic Antagonists; Stereotyped Behavior

1999
Brief report: case reports on naltrexone use in children with autism: controlled observations regarding benefits and practical issues of medication management.
    Journal of autism and developmental disorders, 2001, Volume: 31, Issue:1

    Topics: Attention; Autistic Disorder; Case-Control Studies; Child; Child Behavior Disorders; Child, Preschool; Double-Blind Method; Humans; Male; Naltrexone; Personality Assessment; Social Behavior

2001
Brief report: a double-blind study of naltrexone in infantile autism.
    Journal of autism and developmental disorders, 1992, Volume: 22, Issue:2

    Topics: Adolescent; Arginine Vasopressin; Autistic Disorder; beta-Endorphin; Child; Child, Preschool; Dopamine; Dose-Response Relationship, Drug; Double-Blind Method; Epinephrine; Female; Humans; Male; Naltrexone; Norepinephrine

1992
Clinical effects of naltrexone on autistic behavior.
    American journal of mental retardation : AJMR, 1992, Volume: 97, Issue:1

    Topics: Adult; Aggression; Autistic Disorder; Double-Blind Method; Female; Humans; Institutionalization; Male; Naltrexone; Self-Injurious Behavior; Stereotyped Behavior

1992
A case report of naltrexone treatment of self-injury and social withdrawal in autism.
    Journal of autism and developmental disorders, 1990, Volume: 20, Issue:2

    Topics: Adolescent; Autistic Disorder; Clinical Trials as Topic; Double-Blind Method; Humans; Intellectual Disability; Interpersonal Relations; Male; Naltrexone; Self Mutilation; Social Adjustment; Stereotyped Behavior

1990
Naltrexone in autistic children: a double-blind and placebo-controlled study.
    Psychopharmacology bulletin, 1990, Volume: 26, Issue:1

    Topics: Autistic Disorder; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Naltrexone; Randomized Controlled Trials as Topic

1990
Initial aggravation of self-injurious behavior in autistic patients receiving naltrexone treatment.
    Journal of autism and developmental disorders, 1990, Volume: 20, Issue:4

    Topics: Adult; Autistic Disorder; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Naltrexone; Self Mutilation

1990
Beta-endorphin disregulation in autistic and self-injurious behavior: a neurodevelopmental hypothesis.
    Synapse (New York, N.Y.), 1988, Volume: 2, Issue:3

    Topics: Adult; Autistic Disorder; beta-Endorphin; Clinical Trials as Topic; Developmental Disabilities; Homeostasis; Humans; Male; Naloxone; Naltrexone

1988
Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis.
    American journal of mental retardation : AJMR, 1989, Volume: 93, Issue:6

    Topics: Autistic Disorder; Child; Clinical Trials as Topic; Conditioning, Operant; Double-Blind Method; Extinction, Psychological; Female; Half-Life; Humans; Naloxone; Naltrexone; Reinforcement Schedule; Self Mutilation

1989
Effects of acute administration of naltrexone on cardiovascular function, body temperature, body weight and serum concentrations of liver enzymes in autistic children.
    Developmental pharmacology and therapeutics, 1989, Volume: 12, Issue:3

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Autistic Disorder; Blood Pressure; Body Temperature; Body Weight; Child; Child, Preschool; Electrocardiography; Enzymes; Female; Heart Rate; Hemodynamics; Humans; Male; Naltrexone

1989

Other Studies

21 other study(ies) available for naltrexone and Autistic Disorder

ArticleYear
    Journal of child and adolescent psychopharmacology, 2020, Volume: 30, Issue:10

    Topics: Autistic Disorder; Child; Compulsive Behavior; Humans; Male; Naltrexone; Narcotic Antagonists; Sexual Behavior

2020
[Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form].
    L'Encephale, 2009, Volume: 35, Issue:2

    Topics: Administration, Oral; Autistic Disorder; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Education, Special; France; Humans; Male; Naltrexone; Narcotic Antagonists; Patient Care Team; Physical Therapy Modalities; Psychomotor Disorders; Speech Therapy; Suspensions; Treatment Outcome

2009
Low-dose naltrexone for multiple sclerosis and autism: does its benefit reveal a common cause?
    Medical hypotheses, 2006, Volume: 67, Issue:3

    Topics: Anti-Inflammatory Agents; Autistic Disorder; Dose-Response Relationship, Drug; Humans; Models, Biological; Multiple Sclerosis; Naltrexone; Narcotic Antagonists; Nitric Oxide Synthase Type II

2006
Clinical case report: opiate antagonist and event-related desynchronization in 2 autistic boys.
    Neuropsychobiology, 1995, Volume: 31, Issue:1

    Topics: Alpha Rhythm; Autistic Disorder; Cerebral Cortex; Child; Cortical Synchronization; Humans; Light; Male; Naltrexone; Neural Pathways; Opioid Peptides; Pursuit, Smooth; Thalamus; Visual Perception

1995
Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians.
    Developmental medicine and child neurology, 1995, Volume: 37, Issue:3

    Topics: Autistic Disorder; Brain; Endorphins; Humans; Infant, Newborn; Melatonin; Naloxone; Naltrexone; Self-Injurious Behavior; Serotonin

1995
Case study: paradoxical response to naltrexone treatment of self-injurious behavior.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1995, Volume: 34, Issue:2

    Topics: Adult; Autistic Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Intellectual Disability; Male; Naltrexone; Self-Injurious Behavior

1995
Naltrexone in infantile autism.
    Journal of autism and developmental disorders, 1994, Volume: 24, Issue:2

    Topics: Autistic Disorder; beta-Endorphin; Child; Humans; Long-Term Care; Naltrexone

1994
[Effects of naltrexone on automutilation behavior in autistic psychosis].
    Presse medicale (Paris, France : 1983), 1996, Feb-24, Volume: 25, Issue:7

    Topics: Adult; Autistic Disorder; Humans; Male; Naltrexone; Narcotic Antagonists; Self Mutilation

1996
Hyperactivity and ADHD.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1996, Volume: 35, Issue:10

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Comorbidity; Diagnosis, Differential; Humans; Hyperkinesis; Naltrexone; Narcotic Antagonists

1996
Prognostic significance of depression occurrence in infantile autism.
    Minerva pediatrica, 1996, Volume: 48, Issue:11

    Topics: Adolescent; Antidepressive Agents; Autistic Disorder; Child; Depressive Disorder; Humans; Male; Naltrexone; Prognosis

1996
Naltrexone in children with autism.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1998, Volume: 37, Issue:8

    Topics: Adult; Autistic Disorder; Behavioral Symptoms; Child; Controlled Clinical Trials as Topic; Humans; Naltrexone; Narcotic Antagonists; Outcome Assessment, Health Care

1998
Uncoupling of proopiomelanocortin (POMC) fragments is related to self-injury.
    Peptides, 2000, Volume: 21, Issue:6

    Topics: Adrenocorticotropic Hormone; Autistic Disorder; beta-Endorphin; Humans; Naltrexone; Narcotic Antagonists; Peptide Fragments; Pro-Opiomelanocortin; Self-Injurious Behavior

2000
Naltrexone open trial with a 5-year-old-boy. A social rebound reaction.
    Acta paedopsychiatrica, 1992, Volume: 55, Issue:3

    Topics: Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child, Preschool; Humans; Intellectual Disability; Male; Naltrexone; Personality Assessment; Social Behavior

1992
Effect of naltrexone upon self-injurious behavior, learning and activity: a case study.
    Pharmacology, biochemistry, and behavior, 1991, Volume: 40, Issue:1

    Topics: Adult; Autistic Disorder; Cognition; Humans; Hypnotics and Sedatives; Intellectual Disability; Learning; Male; Memory; Microcephaly; Motor Activity; Naltrexone; Self-Injurious Behavior

1991
Brief report: a synopsis of an open-trial of naltrexone treatment of autism with four children.
    Journal of autism and developmental disorders, 1991, Volume: 21, Issue:2

    Topics: Adolescent; Aggression; Attention; Autistic Disorder; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intellectual Disability; Male; Motor Activity; Naltrexone; Social Behavior; Social Environment

1991
Naltrexone for treatment of self-injury.
    The American journal of psychiatry, 1989, Volume: 146, Issue:12

    Topics: Adult; Autistic Disorder; Female; Humans; Naltrexone; Self Mutilation

1989
Effects on naltrexone on infantile autism.
    Lancet (London, England), 1988, Mar-26, Volume: 1, Issue:8587

    Topics: Autistic Disorder; Child; Child Behavior; Drug Administration Schedule; Female; Humans; Naltrexone

1988
Naltrexone in autistic children: an acute open dose range tolerance trial.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1989, Volume: 28, Issue:2

    Topics: Autistic Disorder; Child; Child, Preschool; Dose-Response Relationship, Drug; Humans; Male; Naltrexone; Stereotyped Behavior

1989
Brain opioids and autism: an updated analysis of possible linkages.
    Journal of autism and developmental disorders, 1987, Volume: 17, Issue:2

    Topics: Autistic Disorder; Brain; Brain Damage, Chronic; Child; Emotions; Endorphins; Humans; Language Development Disorders; Naloxone; Naltrexone; Receptors, Opioid; Serotonin; Social Behavior

1987
Naltrexone in infantile autism.
    Psychopharmacology bulletin, 1988, Volume: 24, Issue:1

    Topics: Autistic Disorder; Child; Child, Preschool; Humans; Male; Naltrexone

1988
Naltrexone in the management of seizures associated with Rett syndrome.
    Drug intelligence & clinical pharmacy, 1987, Volume: 21, Issue:11

    Topics: Autistic Disorder; Female; Gait; Humans; Naltrexone; Seizures; Syndrome

1987